ACE2 and COVID-19: Differences observed in some studies with COVID-19 infected patients could have other reasons since hypertension and diabetes are the most frequent co-morbidities, and these diseases are associated with elevated soluble ACE2 in plasma and thus must be considered significant confounders [77,78].